A photo of Eric Mullins.

Research Director, Hemophilia Treatment Center

Associate Professor, UC Department of Pediatrics



Board Certified

My Biography & Research

Clinical Interests

Care of children and adolescents with bleeding and thrombotic disorders; hemophilia; von Willebrand’s disease; Young Women’s Bleeding Disorder Clinic; disordered menstrual bleeding; Hemophilia Treatment Center

Research Interests

Interaction of coagulation factors with immunity and inflammation; inflammatory diseases; multiple sclerosis; sickle cell disease; mouse models of these diseases; coagulation factor knockouts; how hemostatic factors modify the inflammatory response

Academic Affiliation

Associate Professor, UC Department of Pediatrics


Cancer and Blood Diseases, Thrombosis, Hemophilia, Hematology, Cancer and Blood Diseases

My Locations

My Education

MD: University of Missouri, Columbia, MO.

Residency: Vanderbilt University Medical Center, Nashville, TN, 2001-2004.

Fellowship: Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2004-2007; Pediatric Hemostasis Fellowship, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2007-2008; Chief Fellow, Pediatric Hematology / Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2007-2008.

Board Certifications: Pediatrics, 2004-Present; Pediatric Hematology/Oncology, 2009-Present.

My Publications

Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation. Silva, LM; Lum, AG; Tran, C; Shaw, MW; Gao, Z; Flick, MJ; Moutsopoulos, NM; Bugge, TH; Mullins, ES. Blood. 2019; 134:291-303.

Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. Yang, Y; Stange, A; Schweickert, PG; Lanman, NA; Paul, EN; Monia, BP; Revenko, AS; Palumbo, JS; Mullins, ES; Elzey, BD; et al. Cancer Research. 2019; 79:3417-3430.

Hydrogel-coated polyurethane/urea shape memory polymer foams. Dalton, E; Chai, Q; Shaw, MW; McKenzie, TJ; Mullins, ES; Ayres, N. Journal of Polymer Science. Part A, Polymer Chemistry. 2019; 57:1389-1395.

Elimination of the fibrinogen integrin aMb2-binding motif improves renal pathology in mice with sickle cell anemia. Nasimuzzaman, M; Arumugam, PI; Mullins, ES; James, JM; Vanden Heuvel, K; Narciso, MG; Shaw, MA; McGraw, S; Aronow, BJ; Malik, P. Blood Advances. 2019; 3:1519-1532.

Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia. Gruppo, RA; Malan, D; Kapocsi, J; Nemes, L; Hay, CR M; Boggio, L; Chowdary, P; Tagariello, G; von Drygalski, A; Hua, F; et al. Journal of Thrombosis and Haemostasis. 2018; 16:1984-1993.

Abnormal Uterine Bleeding in Adolescent Women. Mullins, ES; Miller, RJ; Mullins, TL K. Current Pediatrics Reports. 2018; 6:123-131.

Real-world experience with use of Antihemophilic Factor (Recombinant), PEGylated for prophylaxis in severe haemophilia A. Dunn, AL; Ahuja, SP; Mullins, ES. Haemophilia. 2018; 24:e84-e92.

Successful management of concurrent acquired hemophilia A and a lupus anticoagulant in a pediatric hematopoietic stem cell transplant patient. Jones, L; Dandoy, C; Jodele, S; Myers, KC; Luchtman-Jones, L; Quinn, CT; Mullins, E; El-Bietar, J. Bone Marrow Transplantation. 2018; 53:487-489.

Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Montagne, A; Nikolakopoulou, AM; Zhao, Z; Sagare, AP; Si, G; Lazic, D; Barnes, SR; Daianu, M; Ramanathan, A; Go, A; et al. Nature Medicine. 2018; 24:326-337.

Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature. Schaefer, BA; Gruppo, RA; Mullins, ES; Tarango, C. Haemophilia. 2017; 23:904-909.